洞察Nerandomilast抗纤维效应背后的细胞和分子机制
Dennis Reininger1, Felix Wolf1, Christoph H Mayr2
1Boehringer Ingelheim Pharma GmbH & Co KG, Immunology & Respiratory Diseases Research, Biberach an der Riss, Germany.
American journal of respiratory cell and molecular biology
|April 16, 2025
概括
纳兰多米拉斯是一种固酶4B抑制剂,通过降低肌纤维细胞活性和改善内皮屏障功能来减少肺纤维化. 这种药物显示出治疗异常性肺纤维化 (IPF) 的潜力.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 异形性肺纤维化 (IPF) 是一种复杂的肺病,需要多方面的治疗策略.
- 针对多种细胞类型和信号通路对于有效的IPF治疗至关重要.
研究的目的:
- 为了研究nerandomilast的抗纤维作用,一个固酶4B (PDE4B) 抑制剂.
- 在IPF模型中评估纳拉多米拉斯对肌纤维细胞 (MF) 和内皮细胞的影响.
主要方法:
- 利用细胞因子刺激的人类IPF肺纤维细胞 (IPF-HLF) 和RNA测序来评估MF收缩性和分化.
- 使用人类微血管内皮细胞的3D微流体芯片来评估内皮屏障完整性和单细胞粘附.
- 在急性肺损伤的体内小鼠模型中评估了nerandomilast的疗效.
主要成果:
- 涅兰多米拉斯显著抑制了IPF-HLF细胞中的MF收缩性和标记体表达.
- 激活cAMP和G蛋白结合受体 (GPCR) 信号,同时抑制基因激活蛋白激酶 (MAPK) 和转化生长因子β (TGFβ) 信号.
- 在体外和体外模型中减少了微血管透性,单细胞粘附和炎症标志物.
结论:
- 尼兰多米拉斯通过调节TGFβ,MAPK酸酶-1和GPCR信号传递来促进MF脱差并降低收缩性.
- 该药物通过增强内皮结和减少粘附分子表达来减轻血管功能障碍.
- 涅兰多米拉斯特显示出IPF的显著治疗潜力,为其细胞和分子机制提供了洞察力.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
321
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
321
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
98
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
98
02:38Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
01:17Intracellular Signaling Affects Focal Adhesions
2.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.5K